University of Miami's 2nd Biennial Miami Leukemia Symposium

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

2020 Update on CML: What Strategies Can Help Overcome Multi-TKI Resistance or Intolerance?

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Jorge Cortés
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Jorge Cortés
144 views
October 23, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
CML and MPNs: Final Frontiers and New Breakthroughs
21:24
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benef…

Feat. J. Tyner
26:24
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on CML: What Strategies Can Help Overcome Multi-TKI Resi…

Feat. J. Cortés
25:18
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Ph- MPN: What Are the Potential Benefits and Limitati…

Feat. O. Odenike
21:19
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on BPDCN: Efficacy Analysis of Available Standard Therap…

Feat. N. Pemmaraju